ArticleJournal of gastrointestinal oncology2020

Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison.

Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.